175.99
+0.89%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Balchem
From its filings with the US Securities and Exchange Commission
Balchem is based in Montvale, New Jersey and is incorporated in Maryland. Its shares trade on Nasdaq under the ticker BCPC. The SEC classifies its business as chemicals & allied products. In the fiscal year to 31 December 2025, it reported revenue of $1.04bn and net income of $154.8m. At that date it held total assets of $1.69bn and shareholders' equity of $1.26bn. By business, Product Sales Revenue brought in 99.8% of revenue, followed by Royalty Revenue at 0.2%. By region, United States accounted for 73.2%, followed by Foreign Countries at 26.8%.
Balchem Corporation (“Balchem,” the “Company,” “we” or “us”), was incorporated in the State of Maryland in 1967. We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. Our three reportable segments are strategic businesses that offer products and services to different markets: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Sales and production of products outside of our reportable segments and other minor business activities are included in "Other and Unallocated".
The Human Nutrition and Health ("HNH") segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. Choline is recognized to play a key role in the development and structural integrity of brain cell membranes in infants, processing dietary fat, reproductive development and neural functions, such as memory and muscle function. The Company's mineral amino acid chelates, specialized mineral salts, and mineral complexes are used as raw materials for inclusion in premier human nutrition products; proprietary technologies have been combined to create an organic molecule in a form the body can readily assimilate. Sales growth for human nutrition applications is reliant on differentiation from lower-cost competitive products through scientific data, intellectual property and customers' appreciation of brand value.
Quoted from its 10-K, filed 20 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 3 Jun 1986
- Employees
- 1,352
- Website
- balchem.com ↗
- Head office
- 5 PARAGON DRIVE, MONTVALE, NJ, 07645
- Incorporated in
- MD
- Classification
- Chemicals & Allied Products
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Theodore HarrisChairman of the Board, President, Chief Executive Officer, since 2015$6.9m
- Mr. C. Martin BengtssonChief Financial Officer, Executive Vice President$2.4m
- Ms. Hatsuki MiyataExecutive Vice President, Chief Legal Officer and Secretary$1.6m
- Mr. Frederic BonedSenior Vice President, General Manager - Human Nutrition and Health$1.9m
- Mr. Martin ReidSenior Vice President and Chief Supply Chain Officer$1.5m
- Mr. William BackusChief Accounting Officer, Vice President$960,419
- Mr. Matthew WineingerLead Independent Director$248,653
- Mr. David FischerIndependent Director$220,653
- Ms. Kathleen FishIndependent Director$228,653
- Mr. Daniel KnutsonIndependent Director$233,653
- Mr. Olivier RigaudIndependent Director$218,653
- Ms. Monica VicenteIndependent Director$218,653
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 78
- Environment
- 59
- Social
- 99
- Governance
- 78
- Direct emissions (scope 1)
- 48,714 t
- Energy emissions (scope 2)
- 22,941 t
- Value chain emissions (scope 3)
- 470,777 t
- Women in the workforce
- 28%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Balchem Corp has several key strengths that contribute to its success in the market. Firstly, the company has a strong reputation for producing high-quality products, particularly in the food and pharmaceutical industries. This reliability has built trust with customers and allowed the company to maintain long-term partnerships.
- Secondly, Balchem Corp has developed a diverse product portfolio, offering a range of specialty chemicals, ingredients, and nutritional products. This diversity helps the company mitigate risks associated with dependence on a single product or industry.
- Furthermore, the company has a robust research and development department, which enables continuous innovation and adaptation to changing market demands. This focus on technology and product development gives Balchem Corp a competitive edge.
Weaknesses
- Despite its strengths, Balchem Corp also faces several weaknesses that could hinder its growth prospects. Firstly, the company may be vulnerable to changes in raw material prices, as the cost of ingredients could impact profit margins. This risk requires effective supply chain management and hedging strategies.
- Additionally, Balchem Corp's strong focus on research and development may lead to high operating expenses. While this investment in innovation is necessary for the company's growth, it also puts pressure on profitability and requires efficient cost management.
- Lastly, Balchem Corp may struggle with brand awareness in certain markets. As the company looks to expand globally, establishing brand recognition and trust among new consumers may pose a challenge and require strategic marketing efforts.
Opportunities
- Several opportunities exist for Balchem Corp to further capitalize on its strengths and expand its market presence. Firstly, the growing demand for health and wellness products provides a chance for the company to leverage its expertise in nutritional solutions and target new customer segments.
- Moreover, Balchem Corp could explore strategic partnerships or acquisitions to enhance its product offerings and enter new markets. Collaborations with established players or the acquisition of complementary businesses would provide synergistic benefits and accelerate growth.
- Furthermore, expansion into emerging economies presents an opportunity for Balchem Corp, as these markets often have increasing disposable incomes and a rising demand for specialty chemical and ingredient solutions.
Threats
- Balchem Corp must also be wary of potential threats that could impact its business operations. Firstly, intense competition within the industry could erode market share and pricing power. The company needs to continuously monitor competitors' strategies and differentiate its products to maintain a competitive edge.
- Additionally, regulatory changes and compliance requirements can present challenges, particularly in the food and pharmaceutical industries where Balchem Corp operates. Adapting to evolving regulations and ensuring adherence is crucial to avoid penalties or reputational damage.
- Lastly, economic downturns and fluctuations in the global economy could negatively impact demand for Balchem Corp's products. Maintaining a resilient financial position and diversifying its customer base across industries and geographic regions can help mitigate this threat.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.